The shy Angeli and his elusive creature: The HNO route to vasodilation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 5, 2009, Pages

  Paolocci, Nazareno ^a,b,d   Wink, David A ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF PERUGIA   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE; NITRATE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITROXYLAMINIC ACID; SODIUM TRIOXODINITRATE; UNCLASSIFIED DRUG;

AORTA; EDITORIAL; HEART PROTECTION; PRIORITY JOURNAL; PULMONARY ARTERY; VASODILATATION;

ANIMALS; BIOLOGICAL FACTORS; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRITES; NITROGEN OXIDES; OXIDATION-REDUCTION; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 66149146564     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00243.2009     Document Type: Editorial

References (44)

1. Adak S, Wang Q, Stuehr DJ. Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism. J Biol Chem 275: 33554-33561, 2000.
2. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favaloro JL, Triggle CR, Kemp-Harper B. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br J Pharmacol. In press.
3. Angeli A, Angelico F. Reactions of nitroxyl [NOH]. J Chem Soc Abstr 80: I, 322, 1901.
4. - donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318: 279-285, 1995.
5. Bermejo E, Saenz DA, Alberto F, Rosenstein RE, Bari SE, Lazzari MA. Effect of nitroxyl on human platelets function. Thromb Haemost 94: 578-584, 2005. (Pubitemid 41300855)
6. 2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37: 87-96, 2005.
7. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9: 1498-1505, 2003. (Pubitemid 38004777)
8. Dai T, Tian Y, Tocchetti CG, Katori T, Murphy AM, Kass DA, Paolocci N, Gao WD. Nitroxyl increases force development in rat cardiac muscle. J Physiol 580: 951-960, 2007. (Pubitemid 46909044)
9. Dierks EA, Burstyn JN. Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase. Biochem Pharmacol 51: 1593-1600, 1996.
10. Dobmeier KP, Riccio DA, Schoenfisch MH. Xerogel optical sensor films for quantitative detection of nitroxyl. Anal Chem 80: 1247-1254, 2008.
11. Donzelli S, Espey MG, Flores-Santana W, Switzer CH, Yeh GC, Huang J, Stuehr DJ, King SB, Miranda KM, Wink DA. Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine. Free Radic Biol Med 45: 578-584, 2008.
12. Donzelli S, Espey MG, Thomas DD, Mancardi D, Tocchetti CG, Ridnour LA, Paolocci N, King SB, Miranda KM, Lazzarino G, Fukuto JM, Wink DA. Discriminating formation of HNO from other reactive nitrogen oxide species. Free Radic Biol Med 40: 1056-1066, 2006. (Pubitemid 43376015)
13. Ellis A, Li CG, Rand MJ. Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta. Br J Pharmacol 129: 315-322, 2000. (Pubitemid 30072652)
14. Farmer PJ, Sulc F. Coordination chemistry of the HNO ligand with hemes and synthetic coordination complexes. J Inorg Biochem 99: 166-184, 2005. (Pubitemid 39646482)
15. Favaloro JL, Kemp-Harper BK. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Cardiovasc Res 73: 587-596, 2007.
16. Favaloro JL, Kemp-Harper BK. Redox variants of nitric oxide (NO• and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms. Am J Physiol Heart Circ Physiol; doi://10.1152/ajpheart.00008.2009.
17. Fontani M, Costa M. Angelo Angeli, lo Scienziato Timido. Pisa, Italy: Riunione Scientifica della Societa' Chimica Italiana, 2004, p. 10-11.
18. Froehlich JP, Mahaney JE, Keceli G, Pavlos CM, Goldstein R, Redwood AJ, Sumbilla C, Lee DI, Tocchetti CG, Kass DA, Paolocci N, Toscano JP. Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. Biochemistry 47: 13150-13152, 2008.
19. Fukuto JM, Chiang K, Hszieh R, Wong P, Chaudhuri G. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther 263: 546-551, 1992.
20. Fukuto JM, Jackson MI, Kaludercic N, Paolocci N. Examining nitroxyl in biological systems. Methods Enzymol 440: 411-431, 2008.
21. Hoffman MD, Walsh GM, Rogalski JC, Kast J. Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method. Mol Cell Proteomics. In press.
22. - activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertension 41: 1301-1307, 2003.
23. Irvine JC, Favaloro JL, Widdop RE, Kemp-Harper BK. Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Hypertension 49: 885-892, 2007.
24. Katori T, Donzelli S, Tocchetti CG, Miranda KM, Cormaci G, Thomas DD, Ketner EA, Lee MJ, Mancardi D, Wink DA, Kass DA, Paolocci N. Peroxynitrite and myocardial contractility: in vivo versus in vitro effects. Free Radic Biol Med 41: 1606-1618, 2006. (Pubitemid 44550084)
25. Katori T, Hoover DB, Ardell JL, Helm RH, Belardi DF, Tocchetti CG, Forfia PR, Kass DA, Paolocci N. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure. Circ Res 96: 234-243, 2005. (Pubitemid 40209371)
26. Miranda KM, Dutton AS, Ridnour LA, Foreman CA, Ford E, Paolocci N, Katori T, Tocchetti CG, Mancardi D, Thomas DD, Espey MG, Houk KN, Fukuto JM, Wink DA. Mechanism of aerobic decomposition of Angeli's salt (sodium trioxodinitrate) at physiological pH. J Am Chem Soc 127: 722-731, 2005. (Pubitemid 40178747)
27. Miranda KM, Katori T, Torres de Holding CL, Thomas L, Ridnour LA, McLendon WJ, Cologna SM, Dutton AS, Champion HC, Mancardi D, Tocchetti CG, Saavedra JE, Keefer LK, Houk KN, Fukuto JM, Kass DA, Paolocci N, Wink DA. Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in Vivo. J Med Chem 48: 8220-8228, 2005. (Pubitemid 43032530)
28. Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, Espey MG, Kass DA, Feelisch M, Fukuto JM, Wink DA. A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci USA 100: 9196-9201, 2003. (Pubitemid 37033906)
29. Miranda KM, Yamada K, Espey MG, Thomas DD, DeGraff W, Mitchell JB, Krishna MC, Colton CA, Wink DA. Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite. Arch Biochem Biophys 401: 134-144, 2002.
30. + channels (BKCa) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 124: 1131-1140, 1998.
31. Munzel T, Daiber A, Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res 97: 618-628, 2005. (Pubitemid 41416330)
32. Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, Paolocci N. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34: 33-43, 2003. (Pubitemid 36043884)
33. Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, Fukuto JM. The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO. Pharmacol Ther 113: 442-458, 2007.
34. - in failing hearts: independence from beta-adrenergic signaling. Proc Natl Acad Sci USA 100: 5537-5542, 2003.
35. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, Kass DA. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci USA 98: 10463-10468, 2001. (Pubitemid 32803042)
36. Pino RZ, Feelisch M. Bioassay discrimination between nitric oxide (NO•) and nitroxyl (NO) Biochem Biophys Res Commun 201: 54-62, 1994.
37. Saleem M, Ohshima H. Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme. Biochem Biophys Res Commun 315: 455-462, 2004. (Pubitemid 38183128)
38. Tocchetti CG, Wang W, Froehlich JP, Huke S, Aon MA, Wilson GM, Di BG, O'Rourke B, Gao WD, Wink DA, Toscano JP, Zaccolo M, Bers DM, Valdivia HH, Cheng H, Kass DA, Paolocci N. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res 100: 96-104, 2007. (Pubitemid 46066777)
39. Ulich BL, Hollis JM, Snyder LE. Radio detection of nitroxyl (HNO)-1st interstellar NO bond. Astrophys J 217: L105-L108, 1977.
40. Wanstall JC, Jeffery TK, Gambino A, Lovren F, Triggle CR. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br J Pharmacol 134: 463-472, 2001. (Pubitemid 32977891)
41. Wink DA, Feelisch M, Fukuto J, Chistodoulou D, Jourd'heuil D, Grisham MB, Vodovotz Y, Cook JA, Krishna M, DeGraff WG, Kim S, Gamson J, Mitchell JB. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys 351: 66-74, 1998.
42. Wink DA, Miranda KM, Katori T, Mancardi D, Thomas DD, Ridnour L, Espey MG, Feelisch M, Colton CA, Fukuto JM, Pagliaro P, Kass DA, Paolocci N. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. Am J Physiol Heart Circ Physiol 285: H2264-H2276, 2003. (Pubitemid 37443041)
43. Wolin MS. Reactive oxygen species and the control of vascular function. Am J Physiol Heart Circ Physiol 296: H539-H549, 2009.
44. Wong PS, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, Nagasawa HT. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry 37: 5362-5371, 1998. (Pubitemid 28241917)